Imaging in cell-based therapy for neurodegenerative diseases

Area of Science:

• Neuroscience
• Regenerative Medicine
• Medical Imaging

Background:

• Fetal cell transplantation is a developing treatment for neurodegenerative diseases like Parkinson's and Huntington's.
• Early clinical trials are underway, necessitating methods to assess treatment efficacy.
• Evaluating graft survival, integration, and function in the brain is critical.

Purpose of the Study:

• To review the role of in vivo neuroimaging techniques.
• To highlight positron emission tomography (PET) and nuclear magnetic resonance (NMR) for assessing fetal cell transplants.
• To discuss the future of multimodal imaging for monitoring neural repair.

Main Methods:

• Review of current neuroimaging technologies for evaluating cell grafts.
• Focus on Positron Emission Tomography (PET) for sensitivity in assessing tissue viability.
• Exploration of Nuclear Magnetic Resonance (NMR) for neurochemical event imaging.

Main Results:

• PET is the primary tool for evaluating the viability and function of transplanted brain tissue.
• NMR techniques offer new avenues for imaging neurochemical processes in vivo.
• Combined imaging modalities promise comprehensive functional monitoring.

Conclusions:

• Advanced neuroimaging is essential for assessing fetal cell transplantation outcomes.
• PET and NMR are key technologies for monitoring graft performance.
• Multimodal imaging strategies will be vital for optimizing CNS repair therapies.